(ACADEMI study. Circulation. 1999; 99:1540-1547.29. Mehta JL, Romeo F. Inflammation, infection and atherosclerosis. Do antibacterials have a role in the therapy of coronary artery disease Drugs 2000;59:159-70.30. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation, and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 1998; 31:1217-1225. coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A. 1995; 92:6911-6914.11. Campbell LA, O\'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995; 172:585-588.12. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996; 27:1555-1561.13. Ong G, Thomas BJ, Mansfield AO, et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996; 49:102-106.14. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med. 1996; 125:979-982.15. Ericson K, Saldeen GP, Lindquist O, Påhlosn C & Mehta JL. Relationship of Chlamydiae pneumoniae Infection to the Severity of Human Coronary Atherosclerosis. Circulation 2000;101:2568-257116. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998; 97:633-636.17. Moazed TC, Kuo C, Grayston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 1997; 175:883-890.18 Godzik KL, O\'Brien ER, Wang SK, et al. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 1995; 33:2411-2414.19. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996; 64:1614-162020. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role of epithelial cells in Chlamydial pathogenesis. J Clin Invest 1997;99:77-8721. Kol A, Sukhova GK, Litchman AH et. al. Chlamydial Heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor alpha and matrix metalloproteinase expression. Circulation 1998;98:300-30722. Mayr M, Metzler B, Kiechl S, et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Circulation 1999;99:1560-623. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is Chlamydial lipopolysaccharide. Infect Immun 1998;66:5067-7224. Fryer RH, Schwobe EP, Woods ML, et al. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med. 1997; 45:168-174.25. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of acute myocardial infarction. Circulation. 1997; 96:404-407.26. Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes. Lancet. 1997; 350:404-407.27. Gurfinkel E, Bozovich G, Beck E, et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q wave coronary syndromes: The final report of the ROXIS study. Eur Heart J 1999;20:121-728. Anderson JL, Muhlestein JB, Carlquist J, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: the Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation. 1999; 99:1540-1547.29. Mehta JL, Romeo F. Inflammation, infection and atherosclerosis. Do antibacterials have a role in the therapy of coronary artery disease Drugs 2000;59:159-70.30. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation, and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 1998; 31:1217-1225.
